Biomedical subjects
J Sternon
Publications and source records attributed to J Sternon.
[The treatment of arterial hypertension. A plea for personalized therapy].
The authors write in favour of giving a personal touch to the antihypertensive treatment according to the clinical, biological and hemodynamic state of each hypertensive patient. They present a course of medicinal and non medicinal measures adapted to eleven kinds of hypertensive patients. Doing this, they bring out the privileged directions of a diuretic, a beta-blocker, an alpha-blocker, a central acting sympatholytic agent, a calcium channel blocker and a angiotensin converting enzyme inhibitor.
[Schedule of antibiotic therapy for athletes with infections].
Explore the source record for details and available documents.
[Cell-mediated immunity and active pulmonary tuberculosis (author's transl)].
Explore the source record for details and available documents.
[Recent aspects of hepatic immunopathology].
Explore the source record for details and available documents.
[Malignant thymoma, myasthenia, thyroiditis, Gougerot-Sjögren syndrome and alveolo-capillary block. Apropos of a case].
Explore the source record for details and available documents.
[A case of mesenteric venous thrombosis. Review of the literature].
A case is presented in which a venous mesenteric thrombosis necessitated an extended small bowel resection. The postoperative follow-up with its complications is presented. Review of the literature.
[Primary hepatic actinomycosis. Case report with computed tomography study and successful medical treatment (author's transl)].
Explore the source record for details and available documents.
[Leading drugs in 1995: success, failures and uncertainties].
Presentation of drugs most worthy of interest in autumn 1995. Among these, the ACE inhibitors, the HMGCOA inhibitors, the Proton Pump inhibitors, the serotoninergics used against depression and migraine, the endobronchial corticoids and finally the ASA. Review of their successes, failures and uncertainties.
[Acute bronchopulmonary infection in elderly subjects].
The main problems caused by acute bronchopneumopathy in the elderly patients are mentioned. The vulnerability of the elderly patient, the atypical clinical features, the risk of bacterial resistance and the relative frequency of aspiration pneumonia are stressed. The indications for hospitalization and the value of antipneumococcal vaccine, as well as the early takeover, at home, of some hospital antibiotherapies are described, and schemes of first intention antibiotherapy are presented.
[Chronic fatigue syndrome].
The major and minor diagnostic criteria of the chronic fatigue syndrome are described. The stages of the differential diagnosis, the diagnostic strategies and the controversies, while insisting on certain sleeping disorders are discussed. The cause of the syndrome may be a viral infection, and an anxious-depressive state may increase somatic complaints. Patients with chronic fatigue syndrome did not demonstrate a specific response to therapy. Spontaneous remission after a few years is a typical feature of this syndrome.
[Is economic rational opposed to medical rational?].
Economic and medical rationalities could be conciliated. In a view of relative convergence various administrative decisions and new medicosurgical strategies are highlighted. The role of centres promoting continuous medical formation is stressed. They should also organize repetitive information campaigns.
[Drug antagonism].
The mechanisms responsible of either a loss of therapeutic efficiency or a beneficial cancellation of toxic phenomena are reviewed. References are specifically made to antagonists of anti-vitamin K, oral contraceptives, antihypertensive drugs and statin. Concerning the antidotes, the importance of anti-digoxin antibodies, naloxone and flumazenil is emphasised.